Literature DB >> 8718889

The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase.

A J Ganzhorn1, P Lepage, P D Pelton, F Strasser, P Vincendon, J M Rondeau.   

Abstract

The role of lysine residues in the catalytic mechanism of myo-inositol monophosphatase (EC 3.1.3.25) was investigated. The enzyme was completely inactivated by amidination with ethyl acetimidate or reductive methylation with formaldehyde and cyanoborohydride. Activity was retained when the active site was protected with Mg2+, Li+, and D,L-myo-inositol 1-phosphate. Using radiolabeling, peptide mapping, and sequence analysis, Lys-36 was shown to be the protected residue, which is responsible for inactivation. Replacing Lys-36 with glutamine produced a mutant protein, K36Q, with similar affinities for the substrate and the activator Mg2+, but a 50-fold lower turnover number as compared to the wild-type enzyme. Crystallographic studies did not indicate any gross structural changes in the mutant as compared to the native form. Initial velocity data were best described by a rapid equilibrium ordered mechanism with two Mg2+ binding before and a third one binding after the substrate. Inhibition by calcium was unaffected by the mutation, but inhibition by lithium was greatly reduced and became noncompetitive. The pH dependence of catalysis and the solvent isotope effect on kcat are altered in the mutant enzyme. D,L-myo-Inositol 1-phosphate, 4-nitrophenyl phosphate, and D-glucose 6-phosphate are cleaved at different rates by the wild-type enzyme, but with similar efficiency by K36Q. All data taken together are consistent with the hypothesis that modifying or replacing the lysine residue in position 36 decreases its polarizing effect on one of the catalytic metal ions and prevents the efficient deprotonation of the metal-bound water nucleophile.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8718889     DOI: 10.1021/bi9603837

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.

Authors:  Seisuke Fujita; Tetsuo Ohnishi; Shujiro Okuda; Ryo Kobayashi; Satoshi Fukuno; Daisuke Furuta; Takeshi Kikuchi; Takeo Yoshikawa; Norihisa Fujita
Journal:  J Mol Model       Date:  2011-01-07       Impact factor: 1.810

2.  Detection of protein-ligand interactions by NMR using reductive methylation of lysine residues.

Authors:  Sherwin J Abraham; Susanne Hoheisel; Vadim Gaponenko
Journal:  J Biomol NMR       Date:  2008-09-26       Impact factor: 2.835

3.  Differences in lysine pKa values may be used to improve NMR signal dispersion in reductively methylated proteins.

Authors:  Sherwin J Abraham; Tomoyoshi Kobayashi; R John Solaro; Vadim Gaponenko
Journal:  J Biomol NMR       Date:  2009-03-12       Impact factor: 2.835

4.  The rate of hydrolysis of phosphomonoester dianions and the exceptional catalytic proficiencies of protein and inositol phosphatases.

Authors:  Chetan Lad; Nicholas H Williams; Richard Wolfenden
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

5.  Metal ion-mediated substrate-assisted catalysis in type II restriction endonucleases.

Authors:  N C Horton; K J Newberry; J J Perona
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

6.  Dimerization of inositol monophosphatase Mycobacterium tuberculosis SuhB is not constitutive, but induced by binding of the activator Mg2+.

Authors:  Alistair K Brown; Guoyu Meng; Hemza Ghadbane; David J Scott; Lynn G Dover; Jérôme Nigou; Gurdyal S Besra; Klaus Fütterer
Journal:  BMC Struct Biol       Date:  2007-08-28

7.  Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme.

Authors:  Noelia Ferruz; Gary Tresadern; Antonio Pineda-Lucena; Gianni De Fabritiis
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.